IBTA e-News May 2017 released

By 6th June 2017 July 18th, 2017 News archive
[1 June 2017] The IBTA's monthly e-News has now been released and has been emailed to all subscribers. To sign up to receive your copy, click here.

You can read the IBTA e-News May 2017 edition in full online here.

Some of the highlights from this month's include:

  • The IBTA’s free Brain Tumour magazine World Edition 2017/18 is now out. 14,000 copies are shipped free-of-charge to recipients in 111 countries - if you would like to receive a paper copy of Brain Tumour magazine then please register using this form. To read the issue online click here and for previous years’ editions online click here.
  • Analysis of a clinical trial of Optune (a Tumor Treating Fields device) has found that Optune with temozolomide did not negatively impact health-related quality of life, except for itchy skin. Novocure has announced that two new clinical trials will pilot the device in childhood high grade glioma.
  • Findings presented at the American Association of Neurological Surgeons (AANS) 2017 annual meeting have shown that Laser Thermal Therapy (LITT) technology is safe and effective for treating both gliomas and metastatic brain tumours
  • Research published in Scientific Reports has found that people with diabetes and raised blood sugar levels have a reduced risk of glioma
  • Ireland’s first biobank of brain tumour tissue has started to receive clinical samples. The archive will be used for research and diagnostic purposes, with the hope that it will help advance the development of new treatments and therapies.
  • A new UK-based study is to explore whether the Zika virus can act against glioblastoma. Because the virus can cross the blood-brain barrier and targets dividing cells, it is hoped that the research could reveal new techniques for delivering therapies directly into brain tumours.
  • A study published in The Lancet Oncology has found that childhood medulloblastoma can be separated into seven different subgroups, each of which has different biological and clinical characteristics.
  • An upcoming clinical trial for personalised therapy of diffuse intrinsic pontine gliomas (DIPGs) in children will see patient data shared via ‘the cloud’ so that researchers can access results in real-time while the trial is underway.

Our monthly e-News highlights items of interest to our international brain tumour community and is emailed to nearly 7,000 recipients. It gives a round-up of the latest research and treatment developments, news about brain tumour patient organisations around the world, and key forthcoming neuro-oncology scientific and patient conferences. You can sign up to receive the e-News every month by registering here.

To see an archive of existing e-News issues, click here.

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.